1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Generic Drug

The Business of Generics: Market Trends & Strategies Explained

  • Currently 4/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
27 votes

Topics under Generic Drug

Global Generic Drug Industry

The generic drug industry (as a part of the pharmaceutical business) covers the marketing and sale of medication containing the same active ingredients and dosages as brand-name drugs manufactured by the pharmaceutical industry. Drugs can be prescribed under their chemical name without specifying a particular pharmaceutical brand or company. A key benefit of generic drugs is that they usually cost a fraction of the price of brand-name drugs, as much as 80% to 85% less according to the US Food and Drug Administration. For example, Glucotrol, a drug used in the treatment of diabetes, represents a monthly cost to patients of between $42 and $84 for 10 mg tablets; however, the drug’s generic version, Glipizide, costs up to 10 times less at between $4 and $8 per month.

Generic drugs are under the same governance as brand-name drugs and must adhere to the same standards. When brand-name drugs come off patent, the market is opened up to generic versions. Patent protection generally protects a drug’s intellectual property rights for about 20 years, but as the patent is effective from the clinical trial stage, the actual time the drug is on the market can be far less, often between 10 and 14 years. After a patent expires, pharmaceutical companies come under fierce pricing pressure due to competition from their less-expensive generic counterparts.

Generics help reduce government spending on healthcare, accounting in part for a near 5% decrease in US drug spending, reports the FDA. The FDA acts as a governing body for generic drugs to enforce maximum standards of variation with brand-name drugs. However, in an 11-year study, variation in absorption of branded and generic drugs was found to be as little as 3.5%. Such negligible variation could equally exist in a comparison of two branded drugs.

Best-Selling Generic Drugs

Generic drugs took all of the top-10 spots for the most-prescribed drugs in the US last year, as ranked by the IMS Institute for Healthcare Informatics. Only three brand-name drugs ranked in the top 25, highlighting the strong foothold secured by generics.

Possibly further boosting future sales is the looming patent expiration of several of the pharmaceutical world’s star prescription brand-name drugs, for which generics are poised to claim a sizeable market share. Top generic drugs to enter the market this year are expected to be Methylphenidate (an attention deficit hyperactivity disorder drug taking over from Concerta) and Levofloxacin (a copy of antibiotic Levaquin).

Other generics set to take over from brand-name drugs include:

  • Fenofibrate based on the cholesterol drug Tricor
  • Montelukast based on asthma and allergy treatment Singulair
  • Pioglitazone based on the diabetic drug Actos
  • Valsartan based on the high blood pressure medication Diovan

Industry Leaders

BCC Research shows Teva Pharmaceutical Industries to hold just under 20% of the global generic drugs market, followed by Sandoz, with 10% of the market. In joint third place are Watson and Mylan, with 6% each. Together, Teva, Sandoz, Watson, and Mylan hold a combined 40% share of the global market.

Generic Drug Industry Trends

The generic drug market is gaining increasing ground over brand-name pharmaceuticals, with the FDA reporting that generics account for more than 70% of prescription drugs in the US. 

 

Leading Associations

Share

You might be interested in these related markets:

24/7 Customer Support

Talk to Sam

+33 4 37 65 17 06

1-10 of about 400 reports

Global Generic Drug Industry

  • January 2017
    7 pages
  • Generic Drug  

  • World  

    United States  

View report >

Generic Drug Industry Analysis in the US

  • November 2017
    217 pages
  • Pharmaceutical  

    Pharmacy  

    Generic Drug  

  • United States  

View report >

Generic Drug Industry in the US and Europe

  • September 2017
    49 pages
  • Generic Drug  

    Pharmaceutical  

  • United States  

    Europe  

View report >

Generic Drug Markets in Japan - Forecast

  • January 2016
    13 pages
  • Generic Drug  

    Pharmacy  

  • Japan  

View report >

Generic Drug Markets in France

  • June 2017
    12 pages
  • Generic Drug  

    Pharmaceutical  

  • France  

View report >

Generic Drug Industry in the UK

  • January 2015
    57 pages
  • Generic Drug  

  • United Kingdom  

    United States  

View report >

Generic Drug Markets in Canada - Forecast

  • August 2017
    6 pages
  • Generic Drug  

  • Canada  

    North America  

View report >

Generic Drug Industry in China - Forecast

  • January 2016
    12 pages
  • Pharmaceutical  

    Generic Drug  

  • China  

    Asia  

View report >

Generic Drug Industry in the Netherlands - Forecast

  • November 2017
    35 pages
  • Generic Drug  

  • Netherlands  

    Europe  

View report >

Generic Drug Industry in Australia - Forecast

  • January 2017
    9 pages
  • Generic Drug  

    Biosimilar  

  • Australia  

    OECD  

    Oceania  

View report >

Search in Generic Drug Industry (About 400 reports)
Parent industry: Pharmaceutical
Related industries: Drug Delivery, Drug Discovery and Development, OTC, Pharmacy, Prescription Drug, Therapy

About 200 reports

Purchase Reports From Reputable Market Research Publishers
(From € 181 - € 8182)

Generics Global Group of Eight (G8) Industry Guide_2017

Generics Global Group of Eight (G8) Industry Guide_2017 Company Report

  • € 1359
  • Industry report
  • February 2017
  • by MarketLine

Generics Global Group of Eight (G8) Industry Guide_2017SummaryThe G8 Generics industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value ...

United Kingdom: Generics Industry Report € 318 January 2017

Global Generics, MarketLine Company Report € 318 January 2017

Generics Global Industry Guide_2017 Company Report € 1359 February 2017

Azilect (Copy) € 8182 October 2017

Gasoline Generator Market: Residential End Use Sector t ... € 4545 September 2017

Generic Drugs Markets in China € 3636 May 2017

Pharma Leader Series: Top Generic Drug Producers Market ... € 2799 July 2017

Generic Drugs Market Forecast 2017-2027 € 2799 January 2017

The Future of Generic Drugs and Strategies for Commerci ... € 2723 September 2016


ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.